UV Flu Technologies Announces Product Entry of ViraTech UV-400 Air Purifier to Hospitality Sector
CENTERVILLE, MA–(Marketwire – Jun 25, 2010) – UV Flu Technologies, Inc. (OTCBB: UVFT) (the “Company”) is gratified to make known a poignant miracle has been completed by Puravair, Inc. as master distributors of the ViraTech Air Purification product line with a brand brand new conveyance which signals the embracing a cause of the product in to the hospitality, road house and sauna marketplace.
The Seagate Hotel and Spa in Delray Beach, Florida, and the Boston Harbor Hotel, in Boston, MA have been both right away means to visibly safeguard their clients’ illness is obviously positioned as a vital caring with the key of the ViraTech UV-400 air catharsis product. This innovative equipment has been law and FDA privileged as a healing device and is deliberate to be an critical step brazen in on condition which probably any open skill with the capability to responsibly raise air peculiarity simply, easily, effectively and visibly.
“The ViraTech UV-400 was the undiluted match, and execution to the oppulance finish spa,” pronounced William Sander, General Manager of the Seagate Hotel. ”We were vehement about grouping these air purifiers for the hotel. These products essentially kill bacteria, on condition which additional insurance to the guests, which is really critical to us at the Seagate. Healthy guest have a certain knowledge about their stay, which creates them wish to come back. Providing this additional turn of insurance additionally sets us detached from the competition.”
“The Boston Harbor Hotel regularly puts their customers’ illness first,” settled Bill Fegley, President of Puravair. “This skill provides bedrooms for many visitors to the city undergoing healing treatments in internal hospitals, and road house government had the pro-active foreknowledge to deliver the air purifiers to these customers, quite those undergoing cancer treatments. We hold this sold market, which exists opposite the nation at thousands of road house properties which have been located diagonally opposite to illness centers, is potentially immense, and offers a genuine and to skill managers as a illness unwavering selling car which shows they indeed caring about their customers’ and families’ practice at a time in their lives when additional touches can meant the most.”
“Hotels, hospitals, and healing watchful bedrooms have been all a potentially outrageous marketplace for the products,” pronounced John Lennon, President of UV Flu Technologies. “Our record is unique, and to which end, we not long ago undertook a re-branding of the inclination from ViraGuard, to ViraTech, in sequence to improved underscore the significance of technological enrichment in all the products. The ViraTech UV-400 is one of the couple of Indoor Air Quality (‘IAQ’) products in the universe privileged by the FDA for make use of as a healing device, and is written privately to kill over 99% of germ with any pass, and we hold which with all of the brand brand new media contention on air quality, which there is outrageous intensity and need for this superior, maintenance-free and rarely in effect product.”
Further sum per the Company’s business, monetary reports and agreements have been filed as partial of the Company’s successive open avowal as a stating issuer underneath the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission’s (“SEC”) EDGAR database. For some-more information, visit: www.uvflutech.com. For sales: www.puravair.com.
About UV Flu Technologies, Inc. (OTCBB: UVFT)
UV Flu Technologies is an innovative developer, manufacturer and distributor of bio record products primarily targeting the fast flourishing Indoor Air Quality (“IAQ”) attention zone (over $7.7 billion in 2008). The Company manufactures the ViraTech UV-400, which utilizes high-intensity ultraviolet deviation (UV-C) inside a murdering cover which goes over filtration to fall short damaging airborne bacteria, at rates surpassing 99.2% on a first-pass basis. The FDA has released a desired Class II healing inventory which enables UV Flu Technologies to marketplace the product as a healing device. For some-more information, visit: www.uvflutech.com. For sales: www.puravair.com.
Notice Regarding Forward-Looking Statements
This headlines recover contains “forward-looking statements” as which tenure is tangible in Section 27A of the United States Securities Act of 1933, as nice and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press recover which have been not quite chronological have been forward-looking statements and embody any statements per beliefs, plans, expectations or intentions per the future. Such forward-looking statements include, between alternative things, the development, costs and formula of brand brand new commercial operation opportunities. Actual formula could talk about from those projected in any forward-looking statements due to countless factors. Such factors include, between others, the fundamental uncertainties compared with brand brand new projects and growth theatre companies. These forward-looking statements have been done as of the date of this headlines release, and we pretence no requisite to refurbish the forward-looking statements, or to refurbish the reasons because tangible formula could talk about from those projected in the forward-looking statements. Although we hold which any beliefs, plans, expectations and intentions contained in this press recover have been reasonable, there can be no declaration which any such beliefs, plans, expectations or intentions will infer to be accurate. Investors should deliberate all of the inform set onward herein and should additionally impute to the risk factors avowal summarized in the annual inform on Form 10-K for the many brand brand new mercantile year, the quarterly reports on Form 10-Q and alternative continual reports filed from time-to-time with the Securities and Exchange Commission.
ON BEHALF OF THE BOARD
UV Flu Technologies, Inc.
—————————–
John J. Lennon, President & CEO
